Skin Medica Purifying Foaming Wash

Description

SkinMedica® Purifying Foaming Wash is an acne treatment formulation designed to effectively cleanse the skin. It contains salicylic acid, which aids in the removal of excess oil and impurities, contributing to clearer skin and the prevention of new acne blemishes. The product is available in a dosage form of 5 fluid ounces (147.9 mL).

Uses and Indications

This drug is indicated for the treatment of acne. It is a foaming wash containing salicylic acid, which aids in the removal of excess oil and impurities from the skin. This formulation is designed to clear the skin and prevent the formation of new acne blemishes.

Dosage and Administration

Moisten the skin with warm water prior to application. Dispense two full pumps of Purifying Foaming Wash into the palm of the hand and apply by gently massaging over the entire affected area. Rinse thoroughly with water and pat dry.

Healthcare professionals should advise patients to avoid contact with the eyes. In the event of contact, patients should rinse their eyes thoroughly with water.

For initial use, it is recommended that patients start with one application daily. Depending on the individual's response and as directed by a healthcare provider, the frequency may be gradually increased to two or three times daily. If patients experience bothersome dryness or peeling, they should reduce the application frequency to once a day or every other day.

For new users, it is advisable to apply the product sparingly to one or two small affected areas during the first three days. If no discomfort occurs, patients may then follow the previously mentioned dosing instructions.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid concurrent use with other topical acne medications, as this may increase the risk of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

In cases of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay. It is crucial for healthcare providers to educate patients on the importance of adhering to these guidelines to ensure safe and effective use of the product.

Side Effects

For external use only. Patients using this product may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. In such cases, it is advised to limit the use to one topical acne medication at a time to minimize the risk of irritation.

Drug Interactions

Concurrent use of topical acne medications may lead to increased skin irritation and dryness. To minimize the risk of these adverse effects, it is recommended that only one topical acne medication be used at a time. If irritation occurs, the patient should discontinue the use of additional topical agents and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Skin Medica Purifying Foaming Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this product. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For application, it is recommended to start with one application daily to minimize the risk of excessive skin drying. If tolerated, the frequency may be gradually increased to two or three times daily as directed by a healthcare professional. Should bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

For new users, a sensitivity test is advised. The product should be applied sparingly to one or two small affected areas for the first three days. If no discomfort is experienced, the patient may proceed with the recommended application regimen.

Geriatric Use

There is no specific information regarding the use of Skin Medica Purifying Foaming Wash in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when recommending this product to elderly patients, as individual responses may vary. Monitoring for any adverse effects or sensitivities in this population is advisable, given the lack of targeted data.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal impacts associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to weigh the potential benefits against any unknown risks. It is recommended that healthcare providers discuss the implications of medication use during pregnancy with their patients, ensuring informed decision-making.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important to inform patients about the potential for skin irritation and dryness. Patients should be cautioned that using this medication concurrently with another topical acne treatment may increase the likelihood of these side effects. If patients experience irritation, they should be advised to limit their use to one topical acne medication at a time to minimize adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a controlled room temperature ranging from 15° to 30°C (59° to 86°F). Care should be taken to ensure that the product is kept within this temperature range to maintain its efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Skin Medica Purifying Foaming Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)